ロード中...
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer
The treatment of several solid and hematologic malignancies with immune checkpoint inhibitors (against programmed death receptor-1/ligand-1 [PD-1/PD-L1]) has dramatically changed the cancer treatment paradigm. However, no checkpoint inhibitors were previously approved for the treatment of triple-neg...
保存先:
| 出版年: | Bosn J Basic Med Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716092/ https://ncbi.nlm.nih.gov/pubmed/30915922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2019.4204 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|